Economic modeling of polygenic risk prediction of coronary artery disease in childhood

Fouad Bitar1,2, Rana Zareef3, Hussain Ismaeel4

  • 1Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Insights

Polygenic risk scores (PRS) can identify children at high lifetime risk for coronary artery disease (CAD). PRS-guided prevention strategies offer significant cost savings and reduce CAD events by targeting high-risk individuals early.

Area of Science:

  • Cardiovascular Disease Research
  • Genetics and Genomics
  • Preventive Medicine

Background:

  • Coronary artery disease (CAD) risk factors and subclinical pathophysiology originate in childhood.
  • Identifying children for primordial prevention of CAD is challenging.
  • Polygenic risk scores (PRS) offer a DNA-based risk marker from birth for stratifying lifetime CAD risk in children.

Purpose of the Study:

  • To evaluate the clinical utility and cost-effectiveness of PRS-guided CAD prevention in children.
  • To assess the impact of PRS-guided interventions on CAD event reduction and healthcare costs.

Main Methods:

  • A Markov model was employed to compare PRS-guided prevention with standard prevention.
  • The model simulated a hypothetical cohort of 10,000 children.
  • Children in the top 20% of PRS distribution (n=2000) were assumed to receive behavioral interventions.

Main Results:

  • PRS-guided prevention was projected to prevent 72 CAD events among 2000 high-risk children.
  • This represents a 3.6% absolute reduction in CAD events.
  • The intervention demonstrated a significant return on investment of 3614%.

Conclusions:

  • Polygenic risk scores enable early and targeted prevention of CAD in children.
  • PRS-guided prevention strategies improve health outcomes.
  • Implementing PRS-guided prevention is cost-effective, lowering lifetime healthcare costs.

Related Concept Videos

Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
70.3K
Polygenic Traits01:18

Polygenic Traits

11.4K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
321
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.6K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76